Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid Tumors
A focused series of substituted 4H-1,2,6-thiadiazin-4-ones was designed and synthesized to probe the anti-cancer properties of this scaffold.Insights from previous kinase inhibitor programs were used to carefully select several different substitution patterns.Compounds were tested on bladder, prostate, pancreatic, breast, chordoma, Bokcase and lung